Azilsartan - Anti-Hypertensive Drug Marketed at Rs 7.50 a Tablet

Wednesday, May 17, 2017 Drug News
Email Print This Page Comment bookmark
Font : A-A+

*Mankind Pharma, a quality driven pharmaceutical company in India launches Anti-Hypertensive-drug Zolahart (Azilsartan), at an affordable price of Rs 7.50 per tablet. Aiming at reducing the most commonly related disease of Hypertension, the introduction of Zolahart (Azilsartan) at 51% less price, is done with most affordable price.

Zolahart (Azilsartan)


Research by the World Health Organization (WHO), shows that hypertension is one of the leading causes of premature deaths in India. It also exerts substantial public health burden on the cardiovascular health status of India.

Azilsartan, a new generation Anti-hypertensive drug, offers potent and hypertensive patients with comorbid conditions like Diabetes or Chronic Kidney Disease (CKD). The recently launched Angiotensin-receptor-blocker (Azilsartan) is the most potent amongst ARBs and is expected to reduce the proportion of patients of uncontrolled BP considerably.

Speaking on the development, *Mr. R.C. Juneja*, chairman and founder, innovative therapies with assured quality that address primary price. It is with this thought, we decided to launch Zolahart(Azilsartan), the latest Anti-Hypertensive Drug at the most affordable Inspired by Pradhan Mantri Jan Aushadi Scheme to deliver pharmaceuticals products at affordable price, Mankind Pharma with its Make in India approach has set up goals to sustain a balance in the healthcare of the country.


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store